Citigroup’s LIBERATOR MED HLDGS INC (NY) LBMH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-85
Closed 8165
2015
Q4
$0 Buy
+85
New +$247 ﹤0.01% 8182
2015
Q3
Sell
-161
Closed 8146
2015
Q2
$0 Sell
161
-2,994
-95% -$8.67K ﹤0.01% 8014
2015
Q1
$12K Sell
3,155
-3,450
-52% -$11.8K ﹤0.01% 6400
2014
Q4
$19K Buy
6,605
+4,309
+188% +$12.2K ﹤0.01% 6251
2014
Q3
$7K Buy
2,296
+790
+52% +$2.5K ﹤0.01% 6450
2014
Q2
$5K Buy
1,506
+306
+26% +$1.19K ﹤0.01% 6493
2014
Q1
$5K Buy
+1,200
New +$5.26K ﹤0.01% 6618

Citigroup's LBMH Position: Q1 2016 in Review

Citigroup sold out of LIBERATOR MED HLDGS INC (NY) (LBMH) in Q1 2016, closing a stake of 85 shares.

Citigroup first reported a position in LBMH in Q1 2014 and held it in 7 quarters. The position peaked at $19K in Q4 2014. 0 funds tracked by Wall St. Rank hold LBMH as of Q1 2016.

  • Citigroup reported no remaining LIBERATOR MED HLDGS INC (NY) position as of Q1 2016 after selling out during the quarter.
  • Citigroup sold 85 LIBERATOR MED HLDGS INC (NY) shares in Q1 2016.
  • Citigroup first reported a position in LIBERATOR MED HLDGS INC (NY) in Q1 2014 and held it in 7 quarters.
  • Citigroup's LIBERATOR MED HLDGS INC (NY) position peaked at $19K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held LIBERATOR MED HLDGS INC (NY) as of Q1 2016.

Based on Citigroup's 13F filing for Q1 2016, filed 13 May 2016.